SCIENTIFIC HUB

Follow the evidence.

106.816 articles found

Open access

Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer's Disease and Parkinson's Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies.

Hölscher C.

CNS Drugs · 2025-09-12

DOI: 10.1007/s40263-025-01226-zPMID: 40938528

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Current Perspectives and Practices in Infection-Related Movement Disorders (IRMD): Insights from a Survey of Members of the International Parkinson and Movement Disorder Society.

Garg D, Rosca EC, Iacono D, Ugawa Y, Desai S, Yadav R, Mohamed Ibrahim N, Phokaewvarangkul O, Ojha R, Amod F, Holla VV, Prashanth LK, Schneider SA, Pal PK.

Mov Disord Clin Pract · 2025-09-12

DOI: 10.1002/mdc3.70352PMID: 40940314

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Cortical Single-Cell Primers of Abnormal Brain Activity in Parkinson's Disease.

Mirzac D, Glaser MB, Kreis SL, Ringel F, Bange M, Herz DM, Groppa S, Rotaru L, Almeida V, Blech J, Oshaghi M, Kunz S, Klein M, Paulsen J, Luhmann HJ, Bopp T, de Jager PL, Groppa S, Gonzalez-Escamilla G.

Research (Wash D C) · 2025-09-11

DOI: 10.34133/research.0863PMID: 40948939

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.